2365-421x

EJNMMI Radiopharmacy and Chemistry

Springer (Biomed Central Ltd.)

View prefix report (10.1186)

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 175 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact175 DOIs
2

Attach ORCID iDs across 88 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact88 DOIs
3

Deposit reference lists for 32 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact32 DOIs

DOIs for this ISSN

Showing the top 5 of 461 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Targeting of activated fibroblasts for imaging and therapy (10.1186/s41181-019-0069-0)
Abstract ORCID
114.61 195
2 Production of novel diagnostic radionuclides in small medica… (10.1186/s41181-018-0038-z)
Abstract ORCID
100.43 101
3 Alpha-PET with terbium-149: evidence and perspectives for ra… (10.1186/s41181-016-0008-2)
Abstract ORCID
99.11 95
4 47Sc as useful β–-emitter for the radiotheragnostic paradigm… (10.1186/s41181-017-0024-x)
Abstract ORCID
95.42 80
5 44Sc for labeling of DOTA- and NODAGA-functionalized peptide… (10.1186/s41181-016-0013-5)
Abstract ORCID
90.65 64
6 Production and separation of 43Sc for radiopharmaceutical pu… (10.1186/s41181-017-0033-9)
Abstract ORCID
88.54 58
7 Bone targeting compounds for radiotherapy and imaging: *Me(I… (10.1186/s41181-016-0017-1)
Abstract ORCID
84.06 47
8 DATATOC: a novel conjugate for kit-type 68Ga labelling of TO… (10.1186/s41181-016-0007-3)
Abstract ORCID
80.10 39
9 Position paper on requirements for toxicological studies in… (10.1186/s41181-016-0004-6)
Abstract ORCID
78.99 37
10 Automation of the Radiosynthesis of Six Different 18F-labele… (10.1186/s41181-016-0018-0)
Abstract ORCID
78.41 36
11 Evaluation of agonist and antagonist radioligands for somato… (10.1186/s41181-017-0023-y)
Abstract ORCID
70.75 25
12 Improved radiolabeling of DOTATOC with trivalent radiometals… (10.1186/s41181-016-0010-8)
Abstract ORCID
69.90 24
13 Synthesis of an Al18F radiofluorinated GLU-UREA-LYS(AHX)-HBE… (10.1186/s41181-018-0039-y)
Abstract ORCID
69.90 24
14 An updated radiosynthesis of [18F]AV1451 for tau PET imaging (10.1186/s41181-017-0027-7)
Abstract ORCID
68.09 22
15 Generation of fluorescently labeled tracers – which features… (10.1186/s41181-017-0034-8)
Abstract ORCID
65.05 19
16 Optimizing labelling conditions of 213Bi-DOTATATE for precli… (10.1186/s41181-016-0014-4)
Abstract ORCID
63.94 18
17 Futureproofing [18F]Fludeoxyglucose manufacture at an Academ… (10.1186/s41181-018-0048-x)
Abstract ORCID
63.94 18
18 Auger electrons for cancer therapy – a review (10.1186/s41181-019-0075-2)
ORCID
63.76 354
19 New protein deposition tracers in the pipeline (10.1186/s41181-016-0015-3)
Abstract ORCID
62.76 17
20 Improved GMP-compliant multi-dose production and quality con… (10.1186/s41181-016-0009-1)
Abstract ORCID
60.21 15
21 Synthesis, gallium labelling and characterization of P04087,… (10.1186/s41181-016-0021-5)
Abstract ORCID
58.80 14
22 Comparison of desferrioxamine and NODAGA for the gallium-68… (10.1186/s41181-019-0060-9)
Abstract ORCID
58.80 14
23 Editorial - EJNMMI radiopharmacy and chemistry (10.1186/s41181-016-0006-4)
Abstract References ORCID
58.36 5
24 Are we “preparing” radiopharmaceuticals? (10.1186/s41181-016-0011-7)
Abstract ORCID
55.70 12
25 Fully-automated radiosynthesis of the amyloid tracer [11C] P… (10.1186/s41181-019-0065-4)
Abstract ORCID
55.70 12
26 [64Cu]NOTA-pentixather enables high resolution PET imaging o… (10.1186/s41181-016-0020-6)
Abstract ORCID
53.96 11
27 New sensitive method for HEPES quantification in 68Ga-radiop… (10.1186/s41181-020-00093-x)
Abstract ORCID
53.96 11
28 18th European Symposium on Radiopharmacy and Radiopharmaceut… (10.1186/s41181-016-0012-6)
Abstract References ORCID
52.42 4
29 Meeting abstracts from the 21st European Symposium on Radiop… (10.1186/s41181-024-00294-8)
Abstract References ORCID
52.42 4
30 The new Regulation on clinical trials in relation to radioph… (10.1186/s41181-019-0055-6)
Abstract ORCID
52.07 10
31 Production and characterization of no-carrier-added 161Tb as… (10.1186/s41181-019-0063-6)
Abstract
50.63 105
32 The various therapeutic applications of the medical isotope… (10.1186/s41181-019-0066-3)
Abstract
50.11 100
33 18F-labeled tracers targeting fibroblast activation protein (10.1186/s41181-021-00144-x)
ORCID
49.44 94
34 Convergent synthesis of 13N-labelled Peptidic structures usi… (10.1186/s41181-017-0035-7)
Abstract ORCID
47.71 8
35 Preparation and preclinical evaluation of a 68Ga-labelled c(… (10.1186/s41181-018-0043-2)
Abstract ORCID
47.71 8
36 Automated synthesis of [11C]L-glutamine on Synthra HCN plus… (10.1186/s41181-019-0057-4)
Abstract ORCID
47.71 8
37 Automated preparation of clinical grade [68Ga]Ga-DOTA-CP04,… (10.1186/s41181-019-0067-2)
Abstract ORCID
47.71 8
38 Strategies to facilitate the discovery of novel CNS PET liga… (10.1186/s41181-016-0016-2)
Abstract
46.28 70
39 Nomenclature for radiopharmaceuticals, consultation of your… (10.1186/s41181-017-0022-z)
Abstract References ORCID
45.15 3
40 Imaging using radiolabelled targeted proteins: radioimmunode… (10.1186/s41181-020-00094-w)
ORCID
45.15 63
41 Evaluation of polydentate picolinic acid chelating ligands a… (10.1186/s41181-019-0072-5)
Abstract
44.09 57
42 Radiosynthesis and evaluation of an 18F–labeled silicon cont… (10.1186/s41181-017-0036-6)
Abstract ORCID
42.25 6
43 Pretargeting for imaging and therapy in oncological nuclear… (10.1186/s41181-017-0026-8)
Abstract
41.80 46
44 Guidance on validation and qualification of processes and op… (10.1186/s41181-017-0025-9)
Abstract
40.84 42
45 Molecular imaging of multiple sclerosis: from the clinical d… (10.1186/s41181-019-0058-3)
Abstract
40.32 40
46 Current radiotracers to image neurodegenerative diseases (10.1186/s41181-019-0070-7)
Abstract
39.78 38
47 AAZTA5/AAZTA5-TOC: synthesis and radiochemical evaluation wi… (10.1186/s41181-019-0068-1)
Abstract
39.49 37
48 Comparing the use of radiolabeled SSTR agonists and an SSTR… (10.1186/s41181-017-0030-z)
Abstract ORCID
38.91 5
49 Synthesis and preliminary preclinical evaluation of fluorine… (10.1186/s41181-018-0046-z)
Abstract ORCID
38.91 5
50 The N-acetyltransferase 10 inhibitor [11C]remodelin: synthes… (10.1186/s41181-025-00330-1)
Abstract ORCID
38.91 5